Crescent Capital BDC, Inc. (NASDAQ:CCAP) Short Interest Down 30.8% in September

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 87,500 shares, a decrease of 30.8% from the August 31st total of 126,500 shares. Based on an average daily trading volume, of 138,500 shares, the short-interest ratio is currently 0.6 days.

Institutional Trading of Crescent Capital BDC

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Confluence Investment Management LLC raised its stake in Crescent Capital BDC by 3.0% during the second quarter. Confluence Investment Management LLC now owns 71,623 shares of the company’s stock worth $1,345,000 after buying an additional 2,108 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Crescent Capital BDC in the 2nd quarter worth approximately $90,000. Relative Value Partners Group LLC lifted its stake in Crescent Capital BDC by 2.1% in the fourth quarter. Relative Value Partners Group LLC now owns 383,121 shares of the company’s stock valued at $6,659,000 after purchasing an additional 7,834 shares during the last quarter. Tucker Asset Management LLC bought a new position in Crescent Capital BDC during the fourth quarter valued at $167,000. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its position in Crescent Capital BDC by 14.1% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 80,766 shares of the company’s stock worth $1,517,000 after buying an additional 10,000 shares during the last quarter. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Crescent Capital BDC Price Performance

Shares of CCAP traded up $0.06 during mid-day trading on Friday, reaching $18.84. The company had a trading volume of 111,018 shares, compared to its average volume of 136,709. The company’s 50 day simple moving average is $18.38 and its 200 day simple moving average is $18.15. Crescent Capital BDC has a 1-year low of $15.03 and a 1-year high of $19.63. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.40 and a current ratio of 1.40. The company has a market capitalization of $698.25 million, a price-to-earnings ratio of 6.70 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its earnings results on Monday, August 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.58 by $0.01. The firm had revenue of $48.95 million during the quarter, compared to the consensus estimate of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same period last year, the company earned $0.56 earnings per share. Analysts expect that Crescent Capital BDC will post 2.34 EPS for the current year.

Crescent Capital BDC Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th will be given a $0.42 dividend. The ex-dividend date is Monday, September 30th. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 annualized dividend and a yield of 8.92%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 59.79%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Bank of America reduced their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Thursday, August 15th. Wells Fargo & Company decreased their price objective on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $18.80.

View Our Latest Stock Analysis on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Articles

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.